Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Beta Hydroxybutyrate (BHB) is a ketone body produced during states of ketosis, such as fasting or ketogenic diets. Its use to support or treat Metabolic Syndrome is based on emerging scientific interest, but evidence is currently limited and mostly preclinical or mechanistic. Some small clinical studies and animal research suggest that BHB and nutritional ketosis may improve several aspects of Metabolic Syndrome, including insulin sensitivity, glucose regulation, reduced inflammation, and lipid profiles. The main mechanism proposed is that BHB serves as an alternate energy substrate and may modulate signaling pathways related to metabolic health, such as inhibition of the NLRP3 inflammasome and effects on gene expression related to oxidative stress and metabolism.

However, most studies have examined the effects of ketogenic diets as a whole, rather than isolated BHB supplementation. Direct clinical evidence specifically for exogenous BHB's effects on Metabolic Syndrome in humans is sparse. Some pilot studies report modest improvements in metabolic parameters, but larger, well-controlled trials are needed. Current evidence does not yet justify the routine use of BHB supplements for treating Metabolic Syndrome, though ongoing research may clarify its role in the future.

More about Beta Hydroxybutyrate
More about Metabolic Syndrome

Other ingredients used for Metabolic Syndrome

Other health conditions supported by Beta Hydroxybutyrate

Products containing Beta Hydroxybutyrate